The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term symptom burden and quality of life in metastatic melanoma patients treated with checkpoint inhibitors.
 
Maha Mamoor
No Relationships to Disclose
 
Jessica A. Lavery
No Relationships to Disclose
 
Robert Sidlow
Consulting or Advisory Role - Compassionate Care Hospice
 
Lauren J. Rogak
No Relationships to Disclose
 
Bridgette Thom
Stock and Other Ownership Interests - Adma Pharma (I); Adverum (I); Aerie (I); Affimed Therapeutics (I); Alder Biopharmaceuticals (I); Alimera Sciences (I); Amphastar (I); Bellicum Pharmaceuticals (I); Caladrius Biosciences (I); Catalyst Pharmaceuticals (I); Connecture (I); Immunomedics (I); Inotek Pharmaceuticals (I); Krystal Biotech (I); Lipocine (I); Mediwound (I); OncoSec (I); Ophthotech (I); PolarityTE (I); Rocket Pharma (I); Rogers Sciences (I); Sesen Bio (I); Sierra Oncology (I); Stemline Therapeutics (I); Sunesis Pharmaceuticals (I); Tesaro (I); Tesaro (I)
 
Niloufer Khan
Research Funding - Gilead Sciences
 
Shrujal S. Baxi
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Adaptive Biotechnologies; Ascentage Pharma; Beigene; Elucida Oncology; Imvaq Therapeutics; Kleo Pharmaceuticals; Linnaeus Therapeutics; Potenza Therapeutics; Serametrix; Tizona Therapeutics, Inc.; Trieza Therapeutics
Honoraria - American Association for Cancer Research; Esanex; Institut Jules Bordet
Consulting or Advisory Role - Adaptive Biotechnologies; Advaxis; Amgen; Apricity Therapeutics; Array BioPharma; Ascentage Pharma; Astellas Pharma; Bayer; Beigene; Bristol-Myers Squibb; Celgene; Chugai Pharma; F-Star Biotechnology; Genentech; Kleo Pharmaceuticals; Lilly; MedImmune; Merck; Neon Therapeutics; Ono Pharmaceutical; Polaris; Polynoma; Potenza Therapeutics; PsiOxus Therapeutics; PsiOxus Therapeutics; PureTech; Sellas Life Sciences; Serametrix; Surface Oncology; Syndax; Tizona Therapeutics, Inc.; Trieza Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); F-Star Therapeutics; Genentech/Roche (Inst); Incyte (Inst); Leap Therapeutics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - ALPHAVIRUS REPLICON PARTICLES EXPRESSING TRP2; Engineered Vaccinia Viruses for Cancer Immunotherapy; I am a co-inventor and receive royalties for a blood test for monitoring myeloid derived suppressor cells.; I am a co-inventor on a patent for Anti-CD40 agonist mAb fused to Monophosphoryl Lipid A (MPL) for cancer therapy; I am a co-inventor on a patent for CAR+ T cells targeting differentiation antigens as means to treat cancer; I am a co-inventor on a patent for use of oncolytic Newcastle Disease virus.; I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.; I am co-inventor and receive royalties for a patent for immune modulating antibodies.
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen; MedImmune; Novartis; Ono Pharmaceutical; Potenza Therapeutics; Roche; Tizona Therapeutics, Inc.
 
Michael A. Postow
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Incyte; Merck; Newlink Genetics; Novartis
Research Funding - Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)
 
Deborah Korenstein
Consulting or Advisory Role - Vedanta Biosciences (I)
Patents, Royalties, Other Intellectual Property - My husband is a scientist and has a pending patent related to tuberculosis drug targets. (I)